This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignees: Sinai Health System, University Health Network. Active years: 2024-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 15 
2 out of 312 
Years Active: 2024-2025
Title: Innovations in Cancer Detection by Ankur Ravinarayana Chakravarthy
Introduction
Ankur Ravinarayana Chakravarthy is a notable inventor based in Toronto, Canada. He has made significant contributions to the field of cancer detection through his innovative methods. With a total of two patents to his name, his work focuses on advancing the techniques used in identifying cancerous cells.
Latest Patents
Chakravarthy's latest patents include groundbreaking methods for cancer detection and classification using methylome analysis. The first patent describes a method of capturing cell-free methylated DNA from a sample containing less than 100 mg of cell-free DNA. This method involves library preparation for sequencing, the addition of methylated filler DNA, denaturation of the sample, and the use of a binder selective for methylated polynucleotides to capture the cell-free methylated DNA. The second patent outlines a method for detecting the presence of DNA from cancer cells in a subject. This process includes providing a sample of cell-free DNA, library preparation, capturing cell-free methylated DNA, sequencing, and comparing the sequences to identify similarities with control sequences from healthy and cancerous individuals.
Career Highlights
Chakravarthy has worked with prominent institutions such as the University Health Network and Sinai Health System. His experience in these organizations has allowed him to develop and refine his innovative techniques in cancer detection.
Collaborations
Some of his notable coworkers include Daniel Diniz De Carvalho and Scott Victor Bratman. Their collaboration has contributed to the advancement of research in cancer detection methodologies.
Conclusion
Ankur Ravinarayana Chakravarthy's contributions to cancer detection through his innovative patents highlight the importance of research and development in medical technology. His work continues to pave the way for advancements in the early detection and classification of cancer, ultimately benefiting patients and healthcare providers alike.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile